Home » Study Highlights Benefits of Risperdal Consta Over Zyprexa
Study Highlights Benefits of Risperdal Consta Over Zyprexa
Data from the first head-to-head trial of Johnson & Johnson’s injectable Risperdal Consta versus Zyprexa has highlighted the benefits of the former’s schizophrenia drug compared with Eli Lilly’s rival oral product.
Pharma Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May